Top compounds associated with response to TCF20


Feature Type Standardized
Nominal ANOVA
mRNA PHA-793887 GDSC1000 pan-cancer AAC 0.15 1e-06
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA SN-38 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA manumycin A CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA clofarabine CTRPv2 pan-cancer AAC 0.14 5e-06
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA leptomycin B CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 6e-06
Download CSV